FIELD: medicine, pharmaceutics.
SUBSTANCE: what is described is a pharmaceutical composition of polydeoxyribonucleotides extracted from natural sources. The composition contains a fraction of polydeoxyribonucleotides extracted from fish sperm cells, wherein the above polydeoxyribonucleotides possess polymer chains of various molecular weights 70 kDa to 240 kDa.
EFFECT: composition is applicable as a therapeutic agent for treating osteoarticular diseases, especially osteoarthritis by an intra-articular injection to provide a required joint fluid viscosity.
8 cl, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2700582C2 |
| COMPOSITION FOR PREVENTION, RELIEF, OR TREATMENT OF DISEASES OR SYMPTOMS RELATED TO CARTILAGES, INCLUDING HAPLN1 | 2019 |
|
RU2788162C2 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2691946C2 |
| COMBINATION FOR TREATING OSTEOARTHRITIS | 2010 |
|
RU2560844C2 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS AND OSTEOARTHROSIS | 2011 |
|
RU2509569C2 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
| CHONDROITIN FOR APPLICATION IN MEDICINE | 2013 |
|
RU2642964C2 |
| METHOD FOR MANUFACTURING A CELLLESS HYDROGEL FROM WARTON'S JELLY MADE OF HUMAN UMBILICAL CORD FOR INTRA-ARTICLE APPLICATION | 2020 |
|
RU2745995C1 |
| NEW PEPTIDE AND ITS APPLICATION | 2011 |
|
RU2525913C1 |
